The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Insomnia Therapeutics Market Between 2026 And 2030?
The market for insomnia therapeutics has experienced substantial growth in recent years. This market is projected to expand from $3.2 billion in 2025 to $3.38 billion in 2026, registering a compound annual growth rate (CAGR) of 5.7%. Historically, this growth has been driven by factors such as the increasing prevalence of sleep disorders, elevated stress levels and lifestyle-induced insomnia, broad adoption of prescription sleep aids, enhanced accessibility to retail pharmacies, and greater recognition of sleep health importance.
The insomnia therapeutics market size is projected to experience significant growth over the next few years, with its value expected to reach $4.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. This anticipated growth during the forecast period is attributed to factors such as the expansion of digital sleep therapeutics, an increasing inclination towards non-pharmacological treatments, a growing aging population, the rising adoption of wearable sleep devices, and the broader implementation of telehealth-based insomnia management. Prominent trends throughout this period include the increased acceptance of cognitive behavioral therapy for insomnia, a surging demand for non-habit-forming sleep medications, greater usage of orexin receptor antagonists, the development of home-based sleep therapy solutions, and the enhanced integration of sleep tracking into treatment plans.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24255&type=smp
Which Factors Are Influencing The Growth Of The Insomnia Therapeutics Market?
Elevated stress and shifts in lifestyle are anticipated to drive expansion in the insomnia therapeutics market. These refer to psychological and behavioral alterations in daily routines and duties that contribute to emotional strain and disturbed sleep patterns. Escalating stress and lifestyle transformations stem from continuous digital engagement, which blurs work-life divisions and restricts genuine mental recuperation. Insomnia therapeutics are vital, providing efficacious, evidence-based treatments that re-establish sound sleep patterns, alleviate sleep-associated anxiety, and bolster mental health in the face of contemporary pressures. As an illustration, data from the American Psychiatric Association (APA), a US-based organization of psychiatrists, indicated in May 2024 that the proportion of U.S. adults experiencing increased anxiety rose from 32% in 2022 to 37% in 2023, peaking at 43% in 2024. Consequently, elevated stress and altered lifestyles are fueling the expansion of the insomnia therapeutics market.
What Segment Categories Shape The Insomnia Therapeutics Market Segment Landscape?
The insomnia therapeutics market covered in this report is segmented –
1) By Treatment Type: Drugs, Medical Devices
2) By Formulation: Tablets, Capsules, Liquid Solutions, Patches
3) By Route Of Administration: Oral, Intravenous, Transdermal, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Wellness Centers
Subsegments:
1) By Drugs: Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Other Drugs
2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices), Polysomnography Devices, Sleep Tracking Devices, Neurostimulation Devices, Light Therapy Devices
What Trends Are Influencing The Evolution Of The Insomnia Therapeutics Market?
Major companies in the insomnia therapeutics market are prioritizing the development of advanced treatments, such as dual orexin receptor antagonists (DORAs), to offer precise therapeutic solutions with fewer adverse effects and improved safety profiles. A dual orexin receptor antagonist (DORA) refers to a class of medication that works by blocking both orexin-1 and orexin-2 receptors in the brain, thereby promoting sleep by inhibiting the wakefulness signaling pathway, and is commonly utilized in insomnia management. For instance, in June 2023, Idorsia Pharmaceuticals Ltd., a Switzerland-based pharmaceutical company, launched QUVIVIQ (daridorexant), which is a first-in-class dual orexin receptor antagonist (DORA) designed for treating chronic insomnia disorder. This therapy aims to lessen nighttime wakefulness without disrupting natural sleep architecture, ultimately providing patients with improved sleep onset, maintenance, and daytime functioning. Its approval marks a significant breakthrough in insomnia treatment, offering a targeted mechanism of action distinct from traditional sedative-hypnotics and addressing the considerable need for long-term, non-habit-forming therapeutic alternatives.
Who Are The Companies Operating Across The Insomnia Therapeutics Market Value Chain?
Major companies operating in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd., Minerva Neurosciences, Neurim Pharmaceuticals Ltd., Big Health, Cerêve Inc., Innovative Neurological Devices, Neurovalens, Electromedical Products International Inc., Pear Therapeutics, ResMed Inc.
Get The Full Insomnia Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/report/insomnia-therapeutics-global-market-report
Which Region Dominates The Insomnia Therapeutics Market By Market Share?
North America was the largest region in the insomnia therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insomnia therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Insomnia Therapeutics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/insomnia-therapeutics-global-market-report
Browse Through More Reports Similar to the Global Insomnia Therapeutics Market 2026, By The Business Research Company
Insomnia Market Report 2026
https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report
Dental Sleep Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/dental-sleep-medicine-global-market-report
Sleep Testing Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model